Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection
Abstract: The hepatitis delta virus (HDV) is the smallest known human virus, yet it causes great harm to patients co-infected with hepatitis B virus (HBV). As a satellite virus of HBV, HDV requires the surface antigen of HBV (HBsAg) for sufficient viral packaging and spread. The special circumstance of co-infection, albeit only one partner depends on the other, raises many virological, immunological, and pathophysiological questions. In the last years, breakthroughs were made in understanding the adaptive immune response, in particular, virus-specific CD4+ and CD8+ T cells, in self-limited versus persistent HBV/HDV co-infection. Indeed, the mechanisms of CD8+ T cell failure in persistent HBV/HDV co-infection include viral escape and T cell exhaustion, and mimic those in other persistent human viral infections, such as hepatitis C virus (HCV), human immunodeficiency virus (HIV), and HBV mono-infection. However, compared to these larger viruses, the small HDV has perfectly adapted to evade recognition by CD8+ T cells restricted by common human leukocyte antigen (HLA) class I alleles. Furthermore, accelerated progression towards liver cirrhosis in persistent HBV/HDV co-infection was attributed to an increased immune-mediated pathology, either caused by innate pathways initiated by the interferon (IFN) system or triggered by misguided and dysfunctional T cells. These new insights into HDV-specific adaptive immunity will be discussed in this review and put into context with known well-described aspects in HBV, HCV, and HIV infections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Viruses. - 14, 2 (2022) , 198, ISSN: 1999-4915
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2022
- DOI
-
10.3390/v14020198
- URN
-
urn:nbn:de:bsz:25-freidok-2241527
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2022
Ähnliche Objekte (12)
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Hepatitis B vaccine and NK cells: a new player in memory
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Mutational escape from cellular immunity in viral hepatitis: variations on a theme
Role of Immunomodulators in Functional Cure Strategies for HBV
PD-1 and LAG-3: synergistic fostering of T cell exhaustion
Role of immunomodulators in functional cure strategies for HBV
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment
The Q for immune evasion in HCC: ER stress in myeloid cells
CD8+ T cell responses during HCV infection and HCC
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Hepatitis B vaccine and NK cells: a new player in memory
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Mutational escape from cellular immunity in viral hepatitis: variations on a theme
Role of Immunomodulators in Functional Cure Strategies for HBV
PD-1 and LAG-3: synergistic fostering of T cell exhaustion
Role of immunomodulators in functional cure strategies for HBV
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment
The Q for immune evasion in HCC: ER stress in myeloid cells
CD8+ T cell responses during HCV infection and HCC
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Hepatitis B vaccine and NK cells: a new player in memory
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Mutational escape from cellular immunity in viral hepatitis: variations on a theme
Role of Immunomodulators in Functional Cure Strategies for HBV
PD-1 and LAG-3: synergistic fostering of T cell exhaustion
Role of immunomodulators in functional cure strategies for HBV
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment
The Q for immune evasion in HCC: ER stress in myeloid cells
CD8+ T cell responses during HCV infection and HCC